Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and intervention agents

Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and intervention agents

US Patent 6756399 · Granted Jun 29, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biomarkers of immune dysfunction in response to chronic stress, methods of use a2023
Method of diagnosing stage or aggressiveness of breast and prostate cancer based2007
Methods for diagnosing cancer or precancer based upon hnRNP protein expression2002
Method of diagnosing of exposure to toxic agents by measuring distinct pattern i2001
Epithelial protein and DNA thereof for use in early cancer detection2001
Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agent2000
Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agent2000
Epithelial protein and DNA thereof for use in early cancer detection1999
Method for early detection of lung cancer1995
Treatment or diagnosis by endoscopic administration into the lymphatics1990
Monoclonal antibodies against non small cell lung cancer1986